SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (601)5/2/2001 6:09:53 PM
From: nigel bates   of 1784
 
They mentioned advantages in crystallizing GPCR-related and membrane bound proteins?

That rings a bell -

Message 15708446
However, substantial progress in this field has been hampered so far by the frustrating experience that GPCRs are extremely difficult to purify and crystallize. In fact, the naturally abundant visual pigment rhodopsin is the only GPCR with known 3D structure.
m-phasys has overcome a major obstacle by applying its proprietary M-FOLD refolding technology. The large amounts of purified, homogeneous receptors are ideally suited for crystallization experiments...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News